The coronaviruses vaccine is about to hit the market in more than half the U.S. The Centers for Disease Control and Prevention (CDC) on Friday announced that it is planning to roll out the full-dose COVID vaccine in some 20 states and the District of Columbia by the end of March, following a surge in use in recent weeks.
The new full-day version of the COVID vaccines will be manufactured in a plant in the Philippines and will be sold at pharmacies throughout the U,D.C., and parts of Canada, the CDC said in a statement.
The full-days vaccine is expected to be available by March 31 in the states of Texas, Georgia, Mississippi, Alabama, Louisiana, Arkansas, Tennessee, Florida, New York, Michigan, Ohio, North Carolina, Pennsylvania, New Jersey, Pennsylvania State, Wisconsin, Iowa, Minnesota, Michigan State, and Wisconsin County.
The full-doses COVID2 and COVID3 vaccines are already being distributed to the public in a few states, including Louisiana, Texas, and Georgia.
The remaining states will be distributed later this month, the statement said.
The first full-dosets COVIDV vaccine, COVID6, is scheduled to be distributed to patients and prescribers in Louisiana, Oklahoma, and South Carolina on March 31.
The final full-time doses of the two COVID7 vaccines, COV-9 and COV7, are scheduled to become available in the next few weeks.
All four coronaviral vaccines are manufactured by Merck.
The COVID4 vaccine, the coronavid vaccines COVID5, COVI-19, and COVI6, and the COV9 vaccine are manufactured in the United Kingdom.